• Assists behavioural complaints in later childhood when taken during pregnancy and infancy.
• The regulation of emotional behaviour and the central GABAergic system may be via the vagus nerve (gut-brain axis).
• LGG® has demonstrated benefits for childhood atopy and immune development.
• LGG® has been shown a reduction in atopy (allergy and eczema) when taken in the last trimester and during infancy. This may be due to an increase in transforming anti-inflammatory growth factor (TGF-B2) in breast milk. TGF-B2 is a key immunoregulatory anti-inflammatory that inhibits IgE synthesis.
• In late pregnancy, supplementing with LGG® assists maternal glucose metabolism
• LGG® and BB12® may help to reduce the occurrence of central weight gain following childbirth.
• LGG®, when given to infants, enhances the relative levels of key bifidobacterium, including B. breve.
• B. longum (BB536) and B. breve (M-16v) are both human residential bacterial strains that have a modulating action on the gut microbiota of pregnant women and their infants.

Ingredients

LGG® is a registered trademark of Chr. Hansen A/S.

Free from animal products, dairy protein, lactose, eggs, gluten, wheat, nuts and soy protein. Free from artificial colours, flavours and preservatives.

Use Suggestion

Pregnant women - First and second trimester:
Take 1 capsule once daily for maternal health and flora balance.

For the third trimester and throughout breastfeeding:

Take 1 capsule twice daily to support healthy, maternal blood glucose metabolism, infant wellbeing and reduced occurrence of eczema and behavioural complaints.

Infants (from birth):

Empty the contents of 1 capsule and mix with breast milk, formula or water once daily to support baby's gut flora.

Cautions

• Always read the label. Follow the directions for use.
• If symptoms persist, consult your healthcare professional.

Store at 2°C to 8°C. (Refrigerate. Do not freeze).